Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 21 2024 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30 2024 and to consider recommendation of dividend (if any).